Publicaciones en colaboración con investigadores/as de Mayo Clinic (24)

2024

  1. Impact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in HCC: A systematic review and individual patient data meta-analysis

    Journal of Hepatology

2023

  1. Author Correction: Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis (Nature Communications, (2019), 10, 1, (3126), 10.1038/s41467-019-11004-3)

    Nature Communications

  2. Zonation of lipid droplet formation and metabolism in alcohol-associated liver disease

    ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH

2022

  1. Clinical, histological and molecular profiling of different stages of alcohol-related liver disease

    Gut, Vol. 71, Núm. 9, pp. 1856-1866

  2. Correction to: The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study

    The American journal of gastroenterology, Vol. 117, Núm. 5, pp. 818

  3. De Novo Malignancy after Liver Transplantation: Risk Assessment, Prevention, and Management - Guidelines from the ILTS-SETH Consensus Conference

    Transplantation, Vol. 106, Núm. 1, pp. E30-E45

  4. The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study

    American Journal of Gastroenterology, Vol. 117, Núm. 2, pp. 301-310

2021

  1. Integrated Multiomics Reveals Glucose Use Reprogramming and Identifies a Novel Hexokinase in Alcoholic Hepatitis

    Gastroenterology, Vol. 160, Núm. 5, pp. 1725-1740.e2

  2. Lung cancer risk among patients with asthma–chronic obstructive pulmonary disease overlap

    Annals of the American Thoracic Society, Vol. 18, Núm. 11, pp. 1894-1900

  3. Serum transferrin as a biomarker of hepatocyte nuclear factor 4 alpha activity and hepatocyte function in liver diseases

    BMC Medicine, Vol. 19, Núm. 1

  4. Super enhancer regulation of cytokine-induced chemokine production in alcoholic hepatitis

    Nature Communications, Vol. 12, Núm. 1

  5. Use of an adeno-associated virus serotype Anc80 to provide durable cure of phenylketonuria in a mouse model

    Journal of Inherited Metabolic Disease, Vol. 44, Núm. 6, pp. 1369-1381

2020

  1. Proteostasis disturbances and endoplasmic reticulum stress contribute to polycystic liver disease: New therapeutic targets

    Liver International, Vol. 40, Núm. 7, pp. 1670-1685

  2. Serum Transferrin Is an Independent Predictor of Mortality in Severe Alcoholic Hepatitis

    American Journal of Gastroenterology, Vol. 115, Núm. 3, pp. 398-405

2019

  1. Correction: Arterial tortuosity syndrome: 40 new families and literature review (Genetics in Medicine, (2018), 20, 10, (1236-1245), 10.1038/gim.2017.253)

    Genetics in Medicine

  2. Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis

    Nature Communications, Vol. 10, Núm. 1

2018

  1. Arterial tortuosity syndrome: 40 new families and literature review

    Genetics in Medicine, Vol. 20, Núm. 10, pp. 1236-1245

2016

  1. Mutations in GANAB, Encoding the Glucosidase IIα Subunit, Cause Autosomal-Dominant Polycystic Kidney and Liver Disease

    American Journal of Human Genetics, Vol. 98, Núm. 6, pp. 1193-1207

2015

  1. CD8+ T cells undergo activation and programmed death-1 repression in the liver of aged Ae2a,b-/- mice favoring autoimmune cholangitis

    Oncotarget, Vol. 6, Núm. 30, pp. 28588-28606

2010

  1. Immunology and gene therapy: Shoulder to shoulder into the fray

    Molecular Therapy